Vertex Pharmaceuticals INC / Ma (VRTX) SEC Filings — 2024
20 SEC filings for Vertex Pharmaceuticals INC / Ma (VRTX) in 2024.
Filings
- Vertex Pharmaceuticals Files 8-K Disclosure — 8-K · Dec 20, 2024
- Vertex Pharmaceuticals Q3 2024 Update — 10-Q · Nov 5, 2024
- Vertex Pharmaceuticals Files 8-K on Financials — 8-K · Nov 4, 2024
- Vertex Pharmaceuticals Enters Material Definitive Agreement — 8-K · Aug 16, 2024
- Vertex Pharmaceuticals Q2 2024 Update — 10-Q · Aug 2, 2024
- Vertex Pharmaceuticals Files 8-K on Financials — 8-K · Aug 1, 2024
- Vertex Pharmaceuticals Files Routine 8-K — 8-K · Jun 27, 2024
- Vertex Pharmaceuticals Files 8-K — 8-K · May 20, 2024
- Vertex Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · May 15, 2024
- Vertex Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Vertex Pharmaceuticals Files 8-K on Financials — 8-K · May 6, 2024
- Vertex Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 11, 2024
- Vertex Pharmaceuticals INC / Ma SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- Vertex Pharmaceuticals Inc. files DEF 14A with executive compensation details — DEF 14A · Apr 4, 2024
- Vertex Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
- Vanguard Amends Vertex Pharma Stake: No Voting Power Reported — SC 13G/A · Feb 13, 2024
- Capital World Investors Holds 22M Shares of Vertex Pharma — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Maintain 5.037% Stake in Vertex Pharma — SC 13G/A · Feb 9, 2024
- Vertex Pharma Files 8-K on Financial Results, Operations — 8-K · Feb 5, 2024
- BlackRock Discloses Passive Stake in Vertex Pharmaceuticals — SC 13G · Jan 25, 2024